ammonium tungsten antimonate hydroxide oxide has been researched along with idoxuridine in 1 studies
| Studies (ammonium tungsten antimonate hydroxide oxide) | Trials (ammonium tungsten antimonate hydroxide oxide) | Recent Studies (post-2010) (ammonium tungsten antimonate hydroxide oxide) | Studies (idoxuridine) | Trials (idoxuridine) | Recent Studies (post-2010) (idoxuridine) |
|---|---|---|---|---|---|
| 40 | 2 | 0 | 2,905 | 111 | 72 |
| Protein | Taxonomy | ammonium tungsten antimonate hydroxide oxide (IC50) | idoxuridine (IC50) |
|---|---|---|---|
| Thymidine kinase | Macacine alphaherpesvirus 1 | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chermann, JC; Jasmin, C; Ono, K; Souyri-Caporale, M; Tovey, MG | 1 |
1 other study(ies) available for ammonium tungsten antimonate hydroxide oxide and idoxuridine
| Article | Year |
|---|---|
Modulation by the polyoxotungstate HPA-23 of Epstein-Barr virus early antigen expression in Raji cells treated with iododeoxyuridine.
Topics: Antigens, Viral; Antimony; Cell Line; DNA; DNA Polymerase II; DNA-Directed DNA Polymerase; Herpesvirus 4, Human; Humans; Idoxuridine; Interphase; Time Factors; Tungsten; Tungsten Compounds; Virus Activation | 1984 |